FDA CLEARS 53 NMEs IN 1996 -- AVERAGE APPROVAL TIME IS 20.5; NEUROPHARM DRUGS APPEAR READY FOR 1997 CLEARANCE: THREE PARKINSON's THERAPIES POISED FOR APPROVAL